Impact Factor
3.36
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.74
512 total citations
h5-index
29
h5 depth signal
Cited share
72.3%
138 of 191
Total citations
512
Citation footprint
Metric signal
2.69
External metric anchor
Self-citation
12.5%
64 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Japan
532
China
191
Turkey
90
United States
84
South Korea
74
Citing Fields of Research
Biomedical Physics
278
Oncology
160
Radiation & Isotope-Based Techniques
160
Prostate Cancer
150
Cardiology
121
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,636
Articles tracked across the journal lifetime
Indexed publication set
191
138 cited publications
Last 12 months
181
15.1 publications/month
Open access share
31.5%
57 OA publications in the last year
Leading citing country
Japan
532 citing publications
Leading citing field
Biomedical Physics
278 citing publications
Latest tracked publication
12 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Sept. 1987-
v1n1, Sept. 1987-
Active Coverage
Research Focus & Classification
Indexed Subjects
Biomedical Physics
Prostate Cancer
Oncology
Neurodegenerative Disorders
Breast Cancer
Lung Cancer
Endocrinology & Metabolism
Issuing & Sponsoring Bodies
Contributor
Nihon Kakuigakkai
Broad Categories
Nuclear Medicine
Prostate Cancer
Biomedical Physics
Cardiology
Lung Cancer
Auto-Inflammatory Disorders
Endocrinology & Metabolism
MeSH Descriptors
Diagnostic Techniques, Radioisotope
Radioisotopes
Radiotherapy
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s12149-026-02297-8
Open DOI
A cohort electron blood self-dose fraction and its propagated uncertainty for ¹²⁴I PET pre-therapy dosimetry in radioiodine therapy of differentiated thyroid cancer
Objective: Pre-therapy blood–marrow dosimetry for ¹³¹I treatment of differentiated thyroid cancer (DTC) requires serial imaging and blood sampling, limiting clinical adoption. When blood data are unavailable, operators fall back to fixed...
02
03
04
05
DOI 10.1007/s12149-026-02304-y
Open DOI
Head-to-head comparison of ⁶⁸Ga-FAPI and ¹⁸F-FDG PET/CT in intracranial space-occupying lesions
06
07
08
09
10
DOI 10.1007/s12149-026-02290-1
Open DOI
Dose-activity relationship in [131I]NaI therapy for differentiated thyroid carcinoma
Bibliographical & Catalog Notes
Vol. 1 complete in one issue.
Also issued online.
19900912 Not printed on acid-free paper